Abstract: Disclosed are a derivative of a 2,5-diketopiperazine compound, and a preparation method therefor, a pharmaceutical composition thereof and the use thereof. Specifically, disclosed are a compound as represented by formula (I), a stereoisomer thereof, a tautomer thereof or a pharmaceutically acceptable salt thereof, or a solvate of any one of the aforementioned. The compound is new in terms of structure, and has good anti-tumor activity and water solubility.

Abstract: A platform for processing a workpiece includes a transmission mechanism, a plurality of workstations and a plurality of movable vehicles. The transmission mechanism transports the workpiece to be processed to one of the plurality of workstations. Each movable vehicle includes a processing module and a docking interface adapted to connect with a docking station of each workstation. The movable vehicles are each adapted to move in and out of each workstation, and each processing module is adapted to process the workpiece transmitted to the workstation after the movable vehicle is moved in and positioned in the workstation.

Abstract: A crystal form and salt form of a bromine domain protein inhibitor represented by formula (I), a preparation method therefor, and a use of the crystal form and salt form in the preparation of a drug for treating diseases mediated by BET protein.

Abstract: Embodiments of the disclosure provide an information processing method, an information processing apparatus, and a storage medium. The method includes: obtaining source data; encoding sub-data in the source data based on a target word feature vector to obtain hidden feature vectors corresponding to the sub-data, the target word feature vector representing a sentiment feature standard; obtaining a word feature vector corresponding to the source data based on the hidden feature vectors corresponding to the sub-data; and inputting the word feature vector into a preset sentiment classification network to obtain a result of sentiment polarity prediction of the source data. According to the embodiments of the disclosure, the accuracy of sentiment polarity prediction may be improved.

Abstract: The present disclosure relates to oral care compositions comprising amino acids and a cannabinoid. Methods of making and use are further provided.

Abstract: The present invention discloses a fabrication method and use of a ?40 mm large-size and high-contrast fiber optic image inverter, belonging to the field of manufacturing of fiber optic imaging elements. The light-absorbing glass for preparing the ?40 mm large-size and high-contrast fiber optic image inverter consists of the following components in molar percentage: SiO2 60-69.9, Al2O3 1.0-10.0, B2O3 10.1-15.0, Na2O 1.0-8.0, K2O 3.0-10.0, MgO 0.1-1.0, CaO 0.5-5.0, ZnO 0-0.1, TiO2 0-0.1, ZrO2 0.1-1.0, Fe2O3 3.0-6.5, Co2O3 0.1-0.5, V2O5 0.51-1.5 and MoO3 0.1-1.0. The fiber optic image inverter has the advantages of low crosstalk of stray light, high resolution and high contrast.

Abstract: This invention relates to oral care compositions comprising a cannabinoid, and one more source(s) of zinc ions and/or stannous ions. The oral care composition may also comprise one or more stannous source(s). Methods of using and of making these compositions is also disclosed herein.

Abstract: This invention relates to oral care compositions comprising a cannabinoid source, a thickening system, wherein the thickening system comprises xanthan gum and carrageenan, and an orally acceptable carrier. The invention also relates to oral care compositions comprising a cannabinoid source, a surfactant system, wherein the surfactant system comprises an acyl glutamate, a non-silica abrasive (e.g., calcium carbonate or charcoal) and an orally acceptable carrier. Also disclosed are methods of using and of making these compositions.

Abstract: An elongate fuel element is described that has a silicon carbide cladding enclosing a fuel, such as UO2, wherein the fuel is dimensioned relative to the cladding to define gaps at each lateral end of the enclosure sufficiently large such that upon swelling in use, the fuel does not increase the strain on the cladding beyond the limits of the claddings strain tolerance. The lateral gaps at the ends of the fuel allow lateral expansion during swelling that reduces the strain on the cladding.

Abstract: Described herein are oral care compositions comprising—in relevant part—an effective amount of inulin. Methods of making and using these compositions are also described.

Abstract: The present invention provides compositions and methods to enhance cutaneous wound healing in subjects afflicted with, or at risk for, a pulmonary infection and/or a pulmonary injury. More specifically, the embodiments of the present invention relate to using fibrin carrier as a vehicle to topically deliver one or more chemokine onto a cutaneous wound so as to accelerate wound healing.

Abstract: Input data comprises an order to provide a quantity of one or more finished goods to a site. Software is programmed for: accessing information that defines an architecture of a supply chain network comprising a plurality of sites connected by a plurality of path fragments; generating one or more path solutions to fulfill the order; removing one or more loops from the one or more path solutions; generating based on the one or more path solutions and the one or more removed loops, one or more revised path solutions; outputting the one or more revised path solutions for display on a client device; and transmitting, only to computers of the sites of a revised subset of a plurality of path fragments, a plurality of signals to initiate movement of one or more of raw materials or finished goods.

Abstract: A dentifrice composition and a method of making thereof are provided. The dentifrice composition includes an alginate, where the alginate is present in an amount from about 0.01 wt % to about 2 wt %, based on the total weight of the dentifrice composition; zinc compounds, wherein the zinc compounds include zinc oxide and zinc citrate trihydrate, wherein the zinc compounds are present in an amount from about 0.1 wt % to about 2 wt %, based on the total weight of the dentifrice composition; and an abrasive, wherein the abrasive includes calcium carbonate, wherein the abrasive is present in an amount from about 38 wt % to about 50 wt %, based on the total weight of the dentifrice composition.

Abstract: A flow stabilized chip includes a chip mainbody, a buffering chamber and two fluid delivery ports. The chip mainbody has a pipe-connection surface. The buffering chamber is disposed in the chip mainbody. The two fluid delivery ports are disposed on the pipe connection surface and connected to the buffering chamber. The chip mainbody includes, in order from the pipe-connection surface to a bottom of the chip mainbody, a first base plate, a first elastic membrane, a second base plate, a second elastic membrane and a third base plate. The first base plate includes a first opening. The second base plate includes a second opening. The third base plate includes a third opening. The first elastic membrane, the second base plate and the second elastic membrane are stacked in sequence to form the buffering chamber.

Abstract: Input data comprises an order to provide a quantity of one or more finished goods to a site. Software is programmed for: accessing information that defines an architecture of a supply chain network comprising a plurality of sites connected by a plurality of path fragments; generating one or more path solutions to fulfill the order; removing one or more loops from the one or more path solutions; generating based on the one or more path solutions and the one or more removed loops, one or more revised path solutions; outputting the one or more revised path solutions for display on a client device; and transmitting, only to computers of the sites of a revised subset of a plurality of path fragments, a plurality of signals to initiate movement of one or more of raw materials or finished goods.

Abstract: An animal feeding apparatus is related, including a base and a reservoir connected to the base, the medium in the reservoir is driven into or out of the reservoir through a port of the reservoir. The base includes a first cavity communicating with the reservoir, and a second cavity adjacent to and communicating with the first cavity. A piston is movable positioned in the first cavity, and having a first force end away from the reservoir. An activator is movable positioned in the second cavity, and having a second force end away from the reservoir. An linkage member is formed between the first cavity and the second cavity, and engages with the piston and the activator and guide the piston and the activator to move in two opposite directions to get the medium to move into or out of the reservoir. An animal feeding method is also related.

Abstract: The disclosure is directed to processes and methods of reducing bloating and breakage of containers and packaging that house oral care compositions. Also contemplated are products and formulations that are produced or obtained from the processes and methods described herein.

Abstract: This invention relates to oral care compositions, for example comprising a salt of a basic amino acid having a pH in solution of less than 7.5, an abrasive having a pH in solution of less than 7.5, and a fluoride ion source, and an acid selected from the group consisting of: a carboxylic acid (e.g., citric acid, lactic acid, glycolic acid, acetic acid, succinic acid, or fumaric acid), and an inorganic acid, wherein the inorganic acid is not phosphoric acid or sulfuric acid (e.g., wherein the inorganic acid is hydrochloric acid or sodium acid pyrophosphate), and to methods of using and of making these compositions.

Abstract: An oral care composition and methods for the same are disclosed herein. The oral care composition may include an orally acceptable vehicle, an anionic surfactant, and a nonionic surfactant. The anionic surfactant may include a C6-C18 fatty acid glutamate or a salt thereof, and the nonionic surfactant may include a C6-C18 alkyl polyglucoside. A weight ratio of the nonionic surfactant to the anionic surfactant may be from about 0.25:1 to about 9:1, or from about 1.8:1 to about 2.2:1.

Abstract: The invention relates to red blood cell-derived vesicles comprising encapsulated active agents, their use in therapy and methods of production thereof.